Click to copy
Click to copy

Amicus Therapeutics: 2Q Earnings Snapshot

August 8, 2019

CRANBURY, N.J. (AP) _ Amicus Therapeutics Inc. (FOLD) on Thursday reported a loss of $84.6 million in its second quarter.

On a per-share basis, the Cranbury, New Jersey-based company said it had a loss of 36 cents. Losses, adjusted for non-recurring costs, were 34 cents per share.

The results met Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was also for a loss of 34 cents per share.

The pharmaceutical company posted revenue of $44.1 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $41.1 million.

Amicus Therapeutics shares have increased 23% since the beginning of the year. The stock has dropped 24% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FOLD at https://www.zacks.com/ap/FOLD

All contents © copyright 2019 The Associated Press. All rights reserved.